Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Cardiovascular Pharmacology|November 15, 2011
A-kinase anchoring proteins that regulate cardiac remodelingGraeme K Carnegie, Brian T BurmeisterPharmacology & Therapeutics|September 10, 2016
Validating the pharmacogenomics of chemotherapy-induced cardiotoxicity: What is missing?Tarek Magdy, Brian T Burmeister, Paul W BurridgeThe Journal of Biological Chemistry|October 10, 2012
Src homology 2 domain-containing phosphatase 2 (Shp2) is a component of the A-kinase-anchoring protein (AKAP)-Lbc complex and is inhibited by protein kinase A (PKA) under pathological hypertrophic conditions in the heartBrian T Burmeister, Domenico M Taglieri, Li Wang, et al.Experimental Dermatology|July 11, 2012
Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8Françoise Van den Bergh, Steven L Eliason, Brian T Burmeister, et al.The Journal of Biological Chemistry|March 25, 2015
Protein Kinase A (PKA) Phosphorylation of Shp2 Protein Inhibits Its Phosphatase Activity and Modulates Ligand SpecificityBrian T Burmeister, Li Wang, Matthew G Gold, et al.Cellular Signalling|February 17, 2015
UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophyLi Wang, Brian T Burmeister, Keven R Johnson, et al.Plos One|May 10, 2013
AKAP13 Rho-GEF and PKD-binding domain deficient mice develop normally but have an abnormal response to β-adrenergic-induced cardiac hypertrophyMatthew J Spindler, Brian T Burmeister, Yu Huang, et al.Journal of Molecular and Cellular Cardiology|October 29, 2013
The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophyDomenico M Taglieri, Keven R Johnson, Brian T Burmeister, et al.Cell Stem Cell|September 15, 2021
RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapyTarek Magdy, Zhengxin Jiang, Mariam Jouni, et al.Pageof 1